Products

Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Canine Insulin like growth factor binding protein 7 (IGFBP7) ELISA Kit-Sandwich

Name: Canine Insulin like growth factor binding protein 7 (IGFBP7) ELISA Kit-Sandwich
SKU: EK10F752
Rating: 5 (1 reviews)

Cat. No.EK10F752

Product TypeAnimal Immunoassay Kits

Size

Inquiry Now Add to Basket

Product Overview

BioVenic Canine IGFBP7 ELISA Kit-Sandwich is designed for the quantitative determination of Canine IGFBP7 in serum, plasma, tissue homogenate, cell culture supernatant, cell lysate, and other biological fluids using a ELISA method. For research use only.

Specifications

Assay Type ELISA-Sandwich

Specificity The assay kit is specific for Canine IGFBP7.

Target Species Canine

Species Reactivity Canine

Detection Range 0.674-40 ng/mL

Sensitivity 0.125 ng/mL

Reproducibility Intra-Assay: CV < 10%; Inter-Assay: CV < 10%

Assay Time Around 180 min

Sample Requirement Serum, plasma, tissue homogenate, cell culture supernatant, cell lysate, and other biological fluids.

Target Information

Insulin like growth factor binding protein 7 is encoded by the IGFBP7 gene in dogs. IGFBP7 has been used in clinical practice as a biomarker for early diagnosis and prognosis of AKI.

Target/Biomarker Canine IGFBP7

Target Synonym insulin like growth factor binding protein 7; insulin-like growth factor-binding protein 7

Gene ID 608559

UniProt ID A0A8C0PID2

Shipping and Storage

This product is shipped with gel ice packs. It is recommended to store at 2-8 °C (Up to 6 months).

Documents

Datasheet

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

References

Wang, S. et al. Insulin-like growth factor binding proteins in kidney disease. Frontiers in pharmacology. 2021, 12: 807119.